UK markets closed


Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
130.00+1.20 (+0.93%)
At close: 4:59PM CEST
Full screen
Previous close128.80
Bid129.40 x 0
Ask130.00 x 0
Day's range128.20 - 130.20
52-week range101.00 - 142.80
Avg. volume23,629
Market cap3.197B
Beta (5Y monthly)1.42
PE ratio (TTM)45.22
EPS (TTM)2.88
Earnings date12 Aug 2021
Forward dividend & yield4.00 (3.08%)
Ex-dividend date17 Aug 2020
1y target est191.67
  • Globe Newswire

    NNIT A/S: 07/2021 The NNIT Group renews infrastructure management agreement with Novo Nordisk and adjusts the company’s financial outlook

    The NNIT Group renews infrastructure management agreement with Novo Nordisk and adjusts the company’s financial outlook The NNIT Group, a leading provider of IT services and consultancy has entered into an agreement with Novo Nordisk to renew the existing infrastructure agreement which was to expire ultimo 2022. The renewed agreement secures the substantial business with Novo Nordisk for another five years and will cover the operations of Novo Nordisk’s global IT infrastructure, including new se

  • Globe Newswire

    Nnit A/s: 06/2021 New CEO to drive NNIT’s continued strategic journey

    New CEO to drive NNIT’s continued strategic journeyToday, NNIT’s Board of Directors have entered into an agreement with Pär Fors who will join NNIT as CEO as of June 14, 2021. Pär Fors will replace Per Kogut who has served as NNIT’s CEO since 2007. Chairman of the Board Carsten Dilling comments: “To continue NNIT’s strategic journey and take NNIT into its next phase of development, the Board has decided that the time is right for a change in chief executive management. We wish to thank Per Kogut for his tremendous contribution to NNIT over the years and for making an unmistakable and positive mark on NNIT’s development. His great sense of loyalty, high level of energy and ambition as well as sharp customer focus are just a few of his many strong suits. I personally value our close cooperation, which has always been characterized by a very fruitful dialogue. We wish Per Kogut the best of luck in his future endeavors.” Per Kogut has served as the CEO of NNIT from 2007-2021. During this time, he has headed a company in rapid and successful development – from a fully owned subsidiary of Novo Nordisk A/S with one major customer to an independent, publicly listed company servicing an extensive and varied portfolio of customers in Denmark and internationally. Under the leadership of Per Kogut, NNIT has demonstrated strong organic growth combined with strategic and value-adding acquisitions. New CEO joins NNIT from CGI ScandinaviaPär Fors, a Swedish national of 55 years, has a very strong background in the IT business. He is the former CEO of CGI Scandinavia and has previously held executive positions in Logica and WM Data. Among Pär Fors’ clear strengths is a deep understanding of IT services, including high-end business and IT consulting, software development and application- & infrastructure outsourcing services. During his time at CGI, he solidified the company as a leading player for customers on digital transformation journeys and, at the same time, increased both growth and profitability. He also has extensive M&A experience from this role. Last but not least, Pär Fors has a strong business focus and is passionate about building leadership teams with a strong customer focus. He is known for strong results combined with the ability to build a culture where people enjoy working together and can develop their own career paths. Contacts for further information Investor relations: Pernille Fabricius, CFO Tel: +45 3077 9500 pnfa@nnit.comMedia relations: Tina Joanne Hindsbo, Media Relations Manager Tel: +45 3077 9578

  • Globe Newswire

    NNIT A/S: 05/2021 Financial report for the first three months of 2021

    Company announcement 05/2021: Financial report for the first three months of 2021 Revenue increase of 1.2% and an operating profit margin before special items of 6.6% Performance highlights for the first three months of 2021 Revenue increased to DKK 731m, up 1.2% (-1.7% organic) from Q1 2020, driven by: Life Sciences (excluding Novo Nordisk Group) grew to DKK 228m, up 43% (30% organic). This increase was mainly related to the continued significant growth of the Life Sciences International business, where revenues increased by 73% (49% organic) to DKK 159m, while revenue from Life Sciences Denmark increased by 3.0% to DKK 69m. Novo Nordisk Group revenue declined 14% to DKK 159m Private & Public business revenue decreased by 9.0% to DKK 344m, mainly due to the loss of the Pandora agreement, but partly countered by increased sales of Winning Solutions Winning Solutions now constitutes 49% of total revenue, up from 44% in Q1 2020 Operating profit margin before special items was 6.6%, up from 6.5% in Q1 2020 positively impacted by a settlement of DKK 7m within Private & Public Net profit amounted to DKK 31m, down from DKK 35m in Q1 2020 Order backlog for 2021 at the beginning of Q2 2021 amounted to DKK 2,379m, an increase of 4.0% over the same time last year, a positive development considering the change in overall mix towards project-based business Outlook for 2021:Guidance for 2021 is maintained: Revenue growth of 1-4% Operating profit margin before special items of 6-7% Investment level of 5-7% of total revenue excluding acquisitions The outlook may still be influenced by the continued uncertainty relating to the COVID-19 situation Per Kogut, CEO of NNIT, comments: “In Q1 we experienced the continued strong growth within International Life Sciences business, with Excellis performing to plan. Our Private & Public business started to see positive momentum in relation to the Winning Solutions strategy which now constitutes 49% of NNIT revenue. Expectations for 2021 remain positive and we maintain our financial guidance.” Conference call details NNIT will host a teleconference on May 7, 2021 at 9:30 CET to present the financial report for the first three months of 2021. Please visit the NNIT website to access the teleconference, which can be found under ‘Investors – Events & Presentations’. Presentation material will be available on the website approximately one hour prior to the start of the presentation. Conference call details Participant telephone numbers: Denmark: +45 8233 3194 United Kingdom: +44 333 300 9034 Sweden: +46 856 642 705 United States: +1 833 526 8382 Financial calendar 2021 August 12, 2021 Interim report for the first six months of 2021 November 3, 2021 Interim report for the first nine months of 2021 Forward-looking statements This announcement contains forward-looking statements. Words such as ‘believe’, ‘expect’, ‘may’, ‘will’, ‘plan’, ‘strategy’, ‘prospect’, ‘foresee’, ‘estimate’, ‘project’, ‘anticipate’, ‘can’, ‘intend’, ‘outlook’, ‘guidance’, ‘target’ and other words and terms of similar meaning in connection with any discussion of future operating or financial performance identify forward-looking statements. Statements regarding the future are subject to risks and uncertainties that may result in considerable deviations from the outlook set forth. Furthermore, some of these expectations are based on assumptions regarding future events which may prove incorrect. Please also refer to the overview of risk factors in the ‘risk management’ section on page 41-43 of the Annual Report 2020. Contacts for further information Investor relations: Media relations: Pernille Fabricius Tina Joanne Hindsbo CFO Media Relations Manager Tel: +45 3077 9500 Tel: +45 3077 9578 The NNIT Group provides a wide range of IT and consulting services worldwide. Supporting the entire supply chain, we help optimize internal company processes, production, sales and delivery to customers. We are experts in supporting the world’s most regulated industries subject to strict governance of processes, quality and data management and documentation – and in guiding customers on their digital journeys. The Group consists of NNIT A/S and subsidiaries Valiance, SCALES and Excellis Health Solutions. Within these companies, we employ over 3,000 people, primarily within Europe, Asia and the US. In Denmark, home to Group HQ, we are one of the leading IT consultancies, servicing both private and public sector customers across all industries. In other parts of Europe and in USA and Asia, we are solely focused on companies within life sciences. Read more at Attachment 05 05072021 Company announcement Q1 2021_EN_v1